Biotech: Halozyme CEO explains what it looks for in M&A targets [Yahoo! Finance Canada]
Halozyme Therapeutics, Inc. (HALO)
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
halozyme.com/investors/default.aspx
Company Research
Source: Yahoo! Finance Canada
M&A activity in the biotech industry has been forecasted to accelerate in 2026. Dr. Helen Torley, the CEO and president of Halozyme, explains to Julie Hyman the characteristics that the company looks for in biotech companies that are potential acquisition targets. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts Recommended Stories
Show less
Read more
Impact Snapshot
Event Time:
HALO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HALO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HALO alerts
High impacting Halozyme Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HALO
News
- Halozyme Therapeutics (NASDAQ:HALO) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c+)" rating to a "buy (b-)" rating.MarketBeat
- Halozyme to Report Fourth Quarter and Full Year 2025 Financial and Operating Results [Yahoo! Finance]Yahoo! Finance
- Halozyme to Report Fourth Quarter and Full Year 2025 Financial and Operating ResultsPR Newswire
- Biotech: Halozyme CEO explains what it looks for in M&A targets [Yahoo! Finance]Yahoo! Finance
- A Look At Halozyme Therapeutics (HALO) Valuation After Raised 2025 And 2026 Revenue Guidance [Yahoo! Finance]Yahoo! Finance
HALO
Earnings
- 11/3/25 - Beat
HALO
Sec Filings
- 2/11/26 - Form 4
- 2/11/26 - Form 4
- 2/11/26 - Form 4
- HALO's page on the SEC website